Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?
The Centers for Medicare & Medicaid Services proposed a 0.09% increase for 2027 Medicare Advantage payments, causing $90 billion loss in healthcare stocks amid insurer profitability concerns.
3 Articles
3 Articles
Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?
Key PointsSeveral health insurance stocks fell after CMS proposed a meager 2027 rate increase for Medicare Advantage.As the largest Medicare insurer, UnitedHealth Group would be hit hard by the proposed rates.However, the stock seems likely to rebound after the recent plunge.10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) announced its 2025 full-year and fourth-quarter results on Tuesday, Jan. 27, 2026. Despite …
Trump's Flat Rate Medicare Advantage Proposal Is 'Shock To The System,' Risking 20% Earnings Hit, Delaying Healthcare Turnaround - UnitedHealth Group (NYSE:UNH)
Healthcare stocks have been in focus after the Donald Trump administration proposed a near-zero increase in Medicare Advantage payments, catching Wall Street off guard and wiping approximately $90 billion in market value from the sector. A ‘Shock To The System’ The Centers for Medicare and Medicaid Services (CMS) proposed a net average payment increase of just 0.09% for 2027—a figure analysts described as “basically nothing” compared to the 4% t…
CVS stock rebounds after Medicare Advantage rate scare; what investors watch next
NEW YORK, Jan 28, 2026, 11:46 EST — Regular session Shares of CVS Health Corporation climbed roughly 3% on Wednesday, recovering some ground after a sharp drop linked to new U.S. government proposals affecting Medicare Advantage payments. By late morning, the stock had gained 3.1%, reaching $74.22. The rebound follows CVS’s close at $72.00 on Tuesday, marking a 14.15% drop as investors adjusted their view on managed-care risks in healthcare. The…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

